Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus
DOI:
https://doi.org/10.2340/0001555580136139Abstract
Imiquimod is a recently developed imidazoquinolin heterocyclic amine that is an immune response modifier. Treatment with topical 5% imiquimod cream has shown promising results in the treatment of genital warts in immunocompetent individuals. We report here the first case of successful treatment with topical 5% imiquimod cream of facial verrucae in an individual with human immunodeficiency virus.Downloads
Download data is not yet available.
Downloads
Published
2000-03-01
How to Cite
Cutler, K., Kagen, M., Don, P., McAleer, P., & Weinberg, J. (2000). Treatment of facial verrucae with topical imiquimod cream in a patient with human immunodeficiency virus. Acta Dermato-Venereologica, 80(2), 134–135. https://doi.org/10.2340/0001555580136139
Issue
Section
Articles
License
All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.
Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.
